Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA.-Reference-Cited by-同舟云学术

Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA.

Published:2019-03-04 Issue:3 Volume:18 Page:153-161
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Baselyous Youanna¹,De Cocinis Michael¹,Ibrahim Mohammed¹,Kalra Alisa¹,Yacoub Rachel¹,Ahmed Rana¹

Affiliation:

1. Discipline of Pharmacy, School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1589447

Reference37 articles.

1. Celecoxib

2. New insights into the use of currently available non-steroidal anti-inflammatory drugs

3. Cardiovascular risk

4. Celecoxib and cardiovascular risks

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis;Cannabis and Cannabinoid Research;2022-12-28

2. Efficacy and safety of Yaobitong capsule for acute lumbar disc herniation: A protocol for a multi-center randomized controlled trial;Medicine;2022-11-25

3. The public’s views on responsibility for medical errors in Kazakhstan;International Journal of Healthcare Management;2022-07-28

4. Inappropriate use of clinical practices in Canada: a systematic review;Canadian Medical Association Journal;2022-02-27

5. Drug Utilization for Pain Management during Perioperative Period of Total Knee Arthroplasty in China: A Retrospective Research Using Real-World Data;Medicina;2021-05-06